Progress of allogeneic hematopoietic stem cell transplantation / 白血病·淋巴瘤

ABSTRACT

In recent years, the indications of allogeneic hematopoietic stem cell transplantation (allo-HSCT) have been expanded due to the improvement of transplant technique. More attentions have been paid to donor specific anti-human leukocyte antigen antibodies because of the widely application of haploidentical SCT. Relapse remains a hot topic in patients with hematological malignancies who underwent allo-HSCT. Here, the progress of allo-HSCT is discussed according to some reports from 59th American Society of Hematology (ASH) Annual Meeting.